PBH Prestige Consumer Healthcare Inc

Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination

Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination

TARRYTOWN, N.Y., June 17, 2025 (GLOBE NEWSWIRE) -- Medtech Products Inc., a Prestige Consumer Healthcare Inc. company (“Medtech” or “Company”), is voluntarily recalling five lots of Little Remedies® Honey Cough Syrup (the “Product”) due to the presence of Bacillus cereus and loss of shelf-stability. Bacillus cereus (B. cereus) can cause two types of food-borne illnesses. One type is characterized by nausea, vomiting, and stomach cramps that can start 1 to 6 hours after eating or drinking contaminated food. The second type can cause stomach cramps and diarrhea that can start 8 to 16 hours after eating or drinking contaminated food. Diarrhea may be a small volume or profuse and watery. Although healthy individuals may suffer only short-term illness, exposure to high levels of foodborne B. cereus can cause death.

The affected lots were distributed nationwide in the United States through retailers and online from 12/14/2022 through 06/04/2025.

The table below identifies the UPC, lot numbers, and expiration dates of the Little Remedies® Honey Cough Syrup impacted by this recall.

Item UPCLot #Exp. Date
7-56184-10737-9

003911/2025
054501/2026
064002/2026
045005/2026
119812/2026

Little Remedies® Honey Cough Syrup is packaged in a 4 FL OZ (118 mL) amber bottle and is sold in an outer carton with the Lot Code appearing both on the bottle label and on the bottom of the carton (images below).

This recall does not include any other Little Remedies® products.

Bottle Label:



Carton:



No serious adverse events have been reported to date.

All lots of Little Remedies® Honey Cough 4 FL OZ (118 mL) still within expiry are being included in the scope of the recall.

Consumers who have the recalled Product should stop using it immediately and should contact their physician or healthcare provider if they have experienced any problems that may be related to the use of this Product. The company will also offer reimbursement for consumers who have purchased Products from the recalled lots.

Consumers with refund requests or questions regarding this recall can contact Medtech via e-mail at , through its website at , or by phone at (800) 754-8853 on Monday – Friday 8:30-5:30 eastern time.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Complete and submit the report Online:
  • Regular Mail or Fax: Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Photos accompanying this announcement are available at



EN
17/06/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Prestige Consumer Healthcare Inc

 PRESS RELEASE

Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Hon...

Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination TARRYTOWN, N.Y., June 17, 2025 (GLOBE NEWSWIRE) -- Medtech Products Inc., a Prestige Consumer Healthcare Inc. company (“Medtech” or “Company”), is voluntarily recalling five lots of Little Remedies® Honey Cough Syrup (the “Product”) due to the presence of Bacillus cereus and loss of shelf-stability. Bacillus cereus (B. cereus) can cause two types of food-borne illnesses. One type is characterized by nausea, vomiting, and stomach cramps that can start 1 to 6 hours after eatin...

 PRESS RELEASE

Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual...

Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference TARRYTOWN, N.Y., June 09, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will participate in a fireside chat at the Oppenheimer 25th Annual Consumer Growth and E-Commerce Conference virtually on Wednesday, June 11, 2025 at 10:30 a.m. ET. A live webcast of this event will be available at under the "Investors” section and the "Events and Presentations" tab, or by using the following link: For those unable to participate during th...

 PRESS RELEASE

UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 ...

UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings Revenue of $296.5 million in Q4 and $1,137.8 million in fiscal 2025Organic revenue grew 7.9% in Q4 and 1.2% in fiscal 2025Diluted EPS of $4.29 in fiscal 2025; Adjusted fiscal 2025 Diluted EPS of $4.52 grew 7.4% versus adjusted prior yearReduced leverage to 2.4x at year-end driven by strong free cash flow and EBITDA growthInitial fiscal 2026 organic revenue growth and Diluted EPS outlook of approximately 1% to 2% and $4.70 to $4.82, respectively TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) --  P...

 PRESS RELEASE

Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue a...

Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings Revenue of $296.5 million in Q4 and $1,137.8 million in fiscal 2025Organic revenue grew 7.9% in Q4 and 1.2% in fiscal 2025Diluted EPS of $4.29 in fiscal 2025; Adjusted fiscal 2025 Diluted EPS of $4.52 grew 7.4% versus adjusted prior yearReduced leverage to 2.4x at year-end driven by strong free cash flow and EBITDA growthInitial fiscal 2026 organic revenue growth and Diluted EPS outlook of approximately 1% to 2% and $4.70 to $4.82, respectively TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) --  Prestige Con...

 PRESS RELEASE

Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and...

Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results TARRYTOWN, N.Y., April 10, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 fourth quarter and year-end earnings release on Thursday, May 8, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of . To participate in th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch